Oculopharyngeal Muscular Dystrophy Clinical Trials in New York, New York

A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia